Digital laboratory How Wellcome Sanger puts energy efficiency at the heart of its HPC strategy The Wellcome Sanger Institute’s Nathan Cunningham discusses the importance or sustainability in creating a sustainable research infrastructure by balancing high-performance computing (HPC) needs with energy efficiency Latest Content White Paper: How specialised HPC cloud solutions can expedite drug discovery and lower costs Sapio Sciences adds electronic batch record functionality to its GMP LIMS The latest LIMS software for life sciences in 2024 New technologies Scitara joins AWS partner network Albert Invent Raises $7.5 Million to accelerate laboratory science using AI ELN provider creates open source library of laboratory instrument data converters White papers White Paper: How specialised HPC cloud solutions can expedite drug discovery and lower costs Emerging HPC models offer faster, more cost effective and scalable simulations than on-premises or traditional cloud access. Streamline laboratory operations with SaaS LIMS Reduce the burden of software management and empower scientists to focus on their research. Lab of the future: delivering intelligence in real-time In a lab of the future, data is at the forefront of building intelligence. Webcasts Strategies to revolutionise research with seamless data access for scientists - Free Live webinar Free Energy Perturbation: How Computational Chemistry Saves Time In Drug Discovery From Data Silos to Data Flow: Unlocking Your Lab with the Right ELN More content Acquisition continues expansion of medical communication capabilities Digital transformation in the lab, and the role of cloud technology Metabolism prediction added in chemistry software update 2023 State of Tech in Biopharma report reveals tech strategies in era of data and AI Collaboration aims to facilitate regenerative cell therapy product development Pharma partnership showcases instant, secure transfer of analytical data Laboratory data storage – On-premise vs cloud-based solutions Uncovering the mechanisms underlying lack of response to immunotherapy Boosting biotech valuations with cost-efficient addition of key in silico evidence UK government invests £5.5 million in life sciences Ardia enables digital transformation Acquistion expands Optibrium's 3D drug design and visualisation software Pagination Previous page ‹ Previous Page 7 Next page Next ›
